0001596783-22-000075.txt : 20220728
0001596783-22-000075.hdr.sgml : 20220728
20220728195901
ACCESSION NUMBER: 0001596783-22-000075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220726
FILED AS OF DATE: 20220728
DATE AS OF CHANGE: 20220728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hopson Ricky
CENTRAL INDEX KEY: 0001862832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 221116834
MAIL ADDRESS:
STREET 1: CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_165905271597021.xml
FORM 4
X0306
4
2022-07-26
0
0001596783
Catalent, Inc.
CTLT
0001862832
Hopson Ricky
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
0
1
0
0
Pres, Clinical Dev & Supply
Common Stock
2022-07-26
4
S
0
312
106.90
D
17035
D
Common Stock
2022-07-26
4
A
0
651
0
A
17686
D
Common Stock
2022-07-27
4
S
0
591
107.67
D
17095
D
Options to purchase Common Stock
107.63
2022-07-26
4
A
0
2828
0
A
2032-07-26
Common Stock
2828.0
2828
D
Shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units received pursuant to the Issuer's long-term incentive plan. No shares were withheld by or surrendered to the Issuer.
Includes restricted stock units.
The number of securities reported reflects the acquisition since August 30, 2021 of 274 shares of the Issuer's common stock pursuant to the Issuer's Employee Stock Purchase Plan in transactions exempt from Section 16(b).
Restricted stock units (RSUs) received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur three (3) years from the date of award.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
Received by the reporting person pursuant to the Issuer's annual grant to executive officers and other personnel under its long-term incentive plan.
The options vest and become exercisable in four equal annual installments beginning on July 26, 2023.
/s/ Jose Ibietatorremendia, attorney-in-fact
2022-07-28